- Home
- BMRN vs GGB Comparison
BMRN vs GGB Comparison
Compare BMRN & GGB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BMRN | GGB |
|---|---|---|
| Founded | 1996 | 1901 |
| Country | United States | Brazil |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Steel/Iron Ore |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.4B | 9.4B |
| IPO Year | 1999 | 2000 |
Fundamental Metrics
Financial Performance| Metric | BMRN | GGB |
|---|---|---|
| Price | $49.61 | $4.64 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 18 | 2 |
| Target Price | ★ $88.22 | $5.38 |
| AVG Volume (30 Days) | 1.7M | ★ 17.3M |
| Earning Date | 05-04-2026 | 04-27-2026 |
| Dividend Yield | N/A | ★ 2.30% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.54 | N/A |
| Revenue | ★ $1,313,646,000.00 | N/A |
| Revenue This Year | $15.02 | $4.59 |
| Revenue Next Year | $12.23 | $3.46 |
| P/E Ratio | $95.96 | ★ $13.89 |
| Revenue Growth | ★ 17.62 | N/A |
| 52 Week Low | $50.76 | $2.61 |
| 52 Week High | $66.28 | $4.98 |
Technical Indicators
Market Signals| Indicator | BMRN | GGB |
|---|---|---|
| Relative Strength Index (RSI) | 31.83 | 57.89 |
| Support Level | N/A | $4.13 |
| Resistance Level | $56.91 | $4.66 |
| Average True Range (ATR) | 1.85 | 0.15 |
| MACD | -0.25 | -0.03 |
| Stochastic Oscillator | 4.96 | 39.09 |
Price Performance
Historical ComparisonAbout BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.
About GGB Gerdau S.A.
Gerdau SA produces steel and steel products. The company operates in civil construction, agriculture, automotive, iron ore, exports, research and development, and home steel products sectors. It offers products such as nails, rebar, columns, billets, slabs, tribar tutors, mechanical construction bars, and reinforced steel locks. The company's geographical segment includes Brazil Segment; North America Segment; South America Segment as well as Special Steel Operations. It derives the majority of its revenue from the Brazil Operations segment, which includes the long, flat and special steel operations and the iron ore operation located in Brazil and joint ventures and associated companies located in Brazil.